Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-12

Clinical Trial Update: Perimenopausal Effects of Estradiol on Reward Responsiveness [Phase 4]

View source ↗

Summary

Phase 4 trial updating perimenopausal depression assessing estradiol effects on reward responsiveness completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL (Estradiol)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Perimenopausal Depression | Phase 4 | Status: COMPLETED | Results posted: 2019-11-12